Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood

References

• Markowitz L, Unger ER, Human Papillomavirus. in Epidemiology and Prevention of Vaccine-Preventable Diseases, J Hamborsky, A Kroger, S Wolfe, Editors. 2015, Public Health Foundation: Washington D.C. p. 175-186.
   Google Scholar
• Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, Markowitz LE, Singleton JA. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015. MMWR Morb Mortal Wkly Rep 2016; 65(33):850-8; PMID: 27561081; https://doi.org/10.15585/mmwr.mm6533a4
   PubMed Web of Science ®Google Scholar
• Immunization and Infectious Diseases. 2020 Topics & Objectives 2016 12/20/2016 [cited 2016 12/21/2016]; Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
   Google Scholar
• HPV Vaccination as a Public Health Priority. 2014, National Foundation for Infectious Diseases: Bethesda, MD. 2014; [cited 2016 April 21]. Available from: http://www.nfid.org/publications/cta/hpv-call-to-action.pdf
   Google Scholar
• Malik H, Khan FH, Ahsan H. Human papillomavirus: current status and issues of vaccination. Arch Virol 2014; 159(2):199-205; PMID: 24022639; https://doi.org/10.1007/s00705-013-1827-z
   PubMed Web of Science ®Google Scholar
• Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Perinatal transmission of human papilomavirus DNA. Virol J 2009; 6:83; PMID: 19545396; https://doi.org/10.1186/1743-422X-6-83
   PubMedGoogle Scholar
• Genital HPV Infection - Fact Sheet. 2016 January 3, 2017 [cited 2017 January 15]; Available from: https://www.cdc.gov/std/hpv/stdfact-hpv.htm
   Google Scholar
• Ermel AC, Brown DR. Human papillomavirus infections, in Harrison's Principles of Internal Medicine, 19e, D Kasper, et al., Editors. 2015, McGraw-Hill Education: New York, NY.
   Google Scholar
• Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M. Human papillomavirus–associated cancers — United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65(26):661-6 https://doi.org/; PMID: 27387669; https://doi.org/10.15585/mmwr.mm6526a1
   PubMed Web of Science ®Google Scholar
• Human papillomavirus (HPV). Ask the Experts: Diseases & Vaccines 2017 February 13, 2017 [cited 2017 April 7]; Available from: http://www.immunize.org/askexperts/experts_hpv.asp
   Google Scholar
• Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis CR, Markowitz L. MMWR HPV vaccine coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014 - United States. CDC MMWR 2014; 63(29):620-4; PMID: 25055185
   PubMed Web of Science ®Google Scholar
• Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J. CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep 2014; 63(4):69-72; PMID: 24476977
   PubMed Web of Science ®Google Scholar
• Bailey HH, Chuang LT, duPont NC, Eng C, Foxhall LE, Merrill JK, Wollins DS, Blanke CD. American society of clinical oncology statement: Human papillomavirus vaccination for cancer prevention. J Clin Oncol 2016; 34:1803-12; PMID:27069078; https://doi.org/10.1200/JCO.2016.67.2014
   PubMed Web of Science ®Google Scholar
• Gardasil(R) 9 [package insert]. Merck & Co., Inc. Whitehouse Station, NJ; January 2017. [cited January 20, 2017; Available from: http://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf
   Google Scholar
• Kash N, Lee M, Kollipara R, Downing C, Guidry J, Tyring S. Safety and efficacy data on vaccines and immunization to human papillomavirus. J Clin Med 2015; 4(4):614; PMID: 26239350; https://doi.org/10.3390/jcm4040614
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, Moreira EDJ, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-Valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8):711-723; PMID: 25693011; https://doi.org/10.1056/NEJMoa1405044
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA, Jr., Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64(11):300-4; PMID: 25811679
   PubMed Web of Science ®Google Scholar
• Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, et al. Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. Jama 2016; 316(22):2411-21; PMID: 27893068; https://doi.org/10.1001/jama.2016.17615
   PubMed Web of Science ®Google Scholar
• Wellington S October 7, 2016 Approval Letter - GARDASIL 9. [FDA Supplement Approval] 2016 10/07/2016 [cited 2017 04/13/2017]; Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM524629.pdf
   Google Scholar
• Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2016; 65(49):1405-8; PMID: 27977643; https://doi.org/10.15585/mmwr.mm6549a5
   PubMed Web of Science ®Google Scholar
• Diekema DS. Improving childhood vaccination rates. N Engl J Med 2012; 366(5):391-3; PMID: 22296072; https://doi.org/10.1056/NEJMp1113008
   PubMed Web of Science ®Google Scholar
• Emberger J. The HPV vaccine: Overcoming barriers to acceptance of a medical triumph. AMA J Ethics 2015; 17(9):854-7; PMID: 26390208; https://doi.org/10.1001/journalofethics.2015.17.9.msoc1-1509
   PubMedGoogle Scholar
• McKee CBK. Exploring the reasons behind parental refusal of vaccines. J Pediatr Pharmacol Ther 2016; 21(2):104-9; PMID: 27199617; https://doi.org/10.5863/1551-6776-21.2.104
   PubMedGoogle Scholar
• DiAnna Kinder F. Parental refusal of the human papillomavirus vaccine. J Pediatr Health Care 2016; 30(6):551-7; PMID: 26776841; https://doi.org/10.1016/j.pedhc.2015.11.013
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA, Jr., Unger ER. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(Rr-05):1-30; PMID: 25167164
   PubMed Web of Science ®Google Scholar
• Waller J, Marlow LA, Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006; 15(7):1257-61; PMID: 16835320; https://doi.org/10.1158/1055-9965.EPI-06-0041
   PubMed Web of Science ®Google Scholar
• Fuchs EL, Rahman M, Berenson AB. Examining maternal beliefs and human papillomavirus vaccine uptake among male and female children in low-income families. Papillomavirus Res 2016; 2:38-40; PMID: 27042695; https://doi.org/10.1016/j.pvr.2016.02.002
   PubMed Web of Science ®Google Scholar
• Fontenot HB, Fantasia HC, Vetters R, Zimet GD. Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men. Vaccine 2016; 34:6209-16; PMID: 27838067; https://doi.org/10.1016/j.vaccine.2016.10.075
   PubMed Web of Science ®Google Scholar
• Coyne-Beasley T, Hochwalt BE. Protecting women against human papillomavirus: Benefits, barriers, and evidence-based strategies to increase vaccine uptake. N C Med J 2016; 77(6):402-5; PMID: 27864489; https://doi.org/10.18043/ncm.77.6.402
   PubMedGoogle Scholar
• Jena AB, Goldman DP, Seabury SA. Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Intern Med 2015; 175(4):617-23; PMID: 25664968; https://doi.org/10.1001/jamainternmed.2014.7886
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. Sexual activity–related outcomes after human papillomavirus vaccination of 11- to 12-Year-Olds. Pediatrics 2012; 130(5):798-805; PMID: 23071201; https://doi.org/10.1542/peds.2012-1516
   PubMed Web of Science ®Google Scholar
• Smith LM, Kaufman JS, Strumpf EC, Levesque LE. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. Cmaj 2015; 187(2):E74-81; PMID: 25487660; https://doi.org/10.1503/cmaj.140900
   PubMed Web of Science ®Google Scholar
• Mayhew A, Mullins TL, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics 2014; 133(3):404-11; PMID: 24488747; https://doi.org/10.1542/peds.2013-2822
   PubMed Web of Science ®Google Scholar
• Gable J, Eder J, Noonan K, Feemster K. Increasing HPV vaccination rates among adolescents: Challenges and opportunities. Children's Hospital of Philadelphia Research Institute, 2016. [cited 2016 April 21]. Available from: http://policylab.chop.edu/sites/default/files/pdf/publications/INCREASING_HPV_VACCINATION_RATES_AMONG_ADOLESCENTS_0.pdf
   Google Scholar
• Garcini LM, Galvan T, Barnack-Tavlaris JL. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine 2012; 30(31):4588-95; PMID: 22579865; https://doi.org/10.1016/j.vaccine.2012.04.096
   PubMed Web of Science ®Google Scholar
• Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, et al. Physicians' human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med 2014; 46(1):80-4; PMID: 24355675; https://doi.org/10.1016/j.amepre.2013.07.009
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev 2015; 24(11):1673-9; PMID: 26494764; https://doi.org/10.1158/1055-9965.EPI-15-0326
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, O'Leary ST. Parents' perceptions of provider communication regarding adolescent vaccines. Hum Vaccin Immunother 2016; 12:1469-75; PMID:27078515; https://doi.org/10.1080/21645515.2016.1147636
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine 2016; 34(9):1187-92; PMID: 26812078; https://doi.org/10.1016/j.vaccine.2016.01.023
   PubMed Web of Science ®Google Scholar
• Baldwin AS, Denman DC, Sala M, Marks EG, Shay LA, Fuller S, Persaud D, Lee SC, Skinner CS, Wiebe DJ, et al. Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics. Patient Educ Couns 2017; 100(4):736-41; PMID:27912928; https://doi.org/10.1016/j.pec.2016.11.014
   PubMed Web of Science ®Google Scholar
• Rand CM, Vincelli P, Goldstein NP, Blumkin A, Szilagyi PG. Effects of phone and text message reminders on completion of the human papillomavirus vaccine series. J Adolesc Health 2017; 60(1):113-9; PMID:27836533; https://doi.org/10.1016/j.jadohealth.2016.09.011
   PubMed Web of Science ®Google Scholar
• Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care 2014; 28(4):e35-9; PMID: 24200295; https://doi.org/10.1016/j.pedhc.2013.09.001
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29(14):2537-41; PMID: 21300094; https://doi.org/10.1016/j.vaccine.2011.01.065
   PubMed Web of Science ®Google Scholar
• Moss JL, Reiter PL, Dayton A, Brewer NT. Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers. Vaccine 2012; 30(33):4960-3; PMID: 22652406; https://doi.org/10.1016/j.vaccine.2012.05.042
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, Brewer NT. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics 2014; 134(2):e346-53; PMID: 25002671; https://doi.org/10.1542/peds.2013-4257
   PubMed Web of Science ®Google Scholar
• State School Immunization Requirements and Vaccine Exemption Laws. 2015 March 27, 2015 [cited 2017 January 10]; Available from: https://www.cdc.gov/phlp/docs/school-vaccinations.pdf
   Google Scholar
• State Information: HPV Mandates for Children in Secondary Schools. 2016 March 9, 2016 [cited 2017 January 10]; Available from: http://www.immunize.org/laws/hpv.asp
   Google Scholar
• State Information: Exemptions Permitted for State Immunization Requirements. 2017 February 17 2017 [cited 2017 April 14]; Available from: http://www.immunize.org/laws/exemptions.asp
   Google Scholar
• Califano S, Calo WA, Weinberger M, Gilkey MB, Brewer NT. Physician support of HPV vaccination school-entry requirements. Hum Vaccin Immunother 2016; 12(6):1626-32; PMID: 26900726; https://doi.org/10.1080/21645515.2016.1149275
   PubMed Web of Science ®Google Scholar
• Calo WA, Gilkey MB, Shah PD, Moss JL, Brewer NT. Parents' support for school-entry requirements for human papillomavirus vaccination: A national study. Cancer Epidemiol Biomarkers Prev 2016; 25(9):1317-25; PMID: 27543621; https://doi.org/10.1158/1055-9965.EPI-15-1159
   PubMed Web of Science ®Google Scholar
• Das JK, Salam RA, Arshad A, Lassi ZS, Bhutta ZA. Systematic review and meta-analysis of interventions to improve access and coverage of adolescent immunizations. J Adolesc Health 2016; 59(4s):S40-8; PMID: 27664595; https://doi.org/10.1016/j.jadohealth.2016.07.005
   PubMed Web of Science ®Google Scholar
• Moss JL, Reiter PL, Truong YK, Rimer BK, Brewer NT. School entry requirements and coverage of nontargeted adolescent vaccines. Pediatrics 2016; 138(6):1-12; PMID: 27940689; https://doi.org/10.1542/peds.2016-1414
   PubMed Web of Science ®Google Scholar
• Perkins RB, Lin M, Wallington SF, Hanchate AD. Impact of school-entry and education mandates by states on HPV vaccination coverage: Analysis of the 2009-2013 National Immunization Survey-Teen. Hum Vaccin Immunother 2016; 12(6):1615-22; PMID: 27152418; https://doi.org/10.1080/21645515.2016.1150394
   PubMed Web of Science ®Google Scholar
• Farmar A-LM, Love-Osborne K, Chichester K, Breslin K, Bronkan K, Hambidge SJ. Achieving high adolescent HPV vaccination coverage. Pediatrics 2016; 138(5):e1-7; PMID: 27940751; https://doi.org/10.1542/peds.2015-2653
   PubMed Web of Science ®Google Scholar
• Weber C. The 4 Pillars™ Practice Transformation Program: Step-by-step guides to quality improvement in outpatient settings. 2016 [cited 2017 January 10]; Available from: http://cdn2.hubspot.net/hubfs/485312/Innovation_Showcase/2016/Learn_More_Sheets_for_2016_Teams/20._4Pillars.pdf?t=1477060634444
   Google Scholar
• Zimmerman RK, Moehling KK, Lin CJ, Zhang S, Raviotta JM, Reis EC, Humiston SG, Nowalk MP. Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars practice Transformation Program. Vaccine 2016; 35(1):109-17; PMID: 27876200; https://doi.org/10.1016/j.vaccine.2016.11.018
   PubMed Web of Science ®Google Scholar
• McRee AL, Reiter PL, Pepper JK, Brewer NT. Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother 2013; 9(2):306-13; PMID: 23291948; https://doi.org/10.4161/hv.22614
   PubMed Web of Science ®Google Scholar
• Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines 2014; 13(2):235-46; PMID: 24405401; https://doi.org/10.1586/14760584.2013.871204
   PubMed Web of Science ®Google Scholar
• Ng JH, Sobel K, Roth L, Byron SC, Lindley MC, Stokley S. Supporting human papillomavirus vaccination in adolescents: Perspectives from commercial and medicaid health plans. J Public Health Manag Pract 2017; 23(3):283-90; PMID: 27798527; https://doi.org/10.1097/phh.0000000000000440
   PubMed Web of Science ®Google Scholar
• AFIX (Assessment, Feedback, Incentives, and eXchange). 2015 April 15, 2015 [cited 2017 January 10]; Available from: https://www.cdc.gov/vaccines/programs/afix/
   Google Scholar
• Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen. Vaccine 2013; 31(26):2816-21; PMID: 23602667; https://doi.org/10.1016/j.vaccine.2013.04.010
   PubMed Web of Science ®Google Scholar
• Walling EB, Benzoni N, Dornfeld J, Bhandari R, Sisk BA, Garbutt J, Colditz G. Interventions to improve HPV vaccine uptake: A systematic review. Pediatrics 2016; 138(1):1-11; PMID: 27296865; https://doi.org/10.1542/peds.2015-3863
   PubMed Web of Science ®Google Scholar
• Cates W, Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26(4 Suppl):S2-7; PMID: 10227693; https://doi.org/10.1097/00007435-199904001-00002
   PubMed Web of Science ®Google Scholar
• Delere Y, Schuster M, Vartazarowa E, Hansel T, Hagemann I, Borchardt S, Perlitz H, Schneider A, Reiter S, Kaufmann AM. Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years. J Clin Microbiol 2011; 49(10):3519-22; PMID: 21813722; https://doi.org/10.1128/JCM.01026-11
   PubMed Web of Science ®Google Scholar
• Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 2014; 41(11):660-4; PMID: 25299412; https://doi.org/10.1097/OLQ.0000000000000193
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338(7):423-8; PMID: 9459645; https://doi.org/10.1056/NEJM199802123380703
   PubMed Web of Science ®Google Scholar
• Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357(9271):1831-6; PMID: 11410191; https://doi.org/10.1016/S0140-6736(00)04956-4
   PubMed Web of Science ®Google Scholar
• Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191(2):182-92; PMID: 15609227; https://doi.org/10.1086/426867
   PubMed Web of Science ®Google Scholar
• Owusu-Edusei K, Jr., Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, Kent CK. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis 2013; 40(3):197-201; PMID: 23403600; https://doi.org/10.1097/OLQ.0b013e318285c6d2
   PubMed Web of Science ®Google Scholar
• Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012; 30(42):6016-9; PMID: 22867718; https://doi.org/10.1016/j.vaccine.2012.07.056
   PubMed Web of Science ®Google Scholar
• Bogaards JA, Coupe VM, Xiridou M, Meijer CJ, Wallinga J, Berkhof J. Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology 2011; 22(4):505-15; PMID: 21540743; https://doi.org/10.1097/EDE.0b013e31821d107b
   PubMed Web of Science ®Google Scholar
• Saraiya M, McCaig LF, Ekwueme DU. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States. Am J Manag Care 2010; 16(6):e137-44; PMID: 20536271
   PubMed Web of Science ®Google Scholar
• Demarteau N, Breuer T, Standaert B. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program. Pharmacoeconomics 2012; 30(4):337-53; PMID: 22409292; https://doi.org/10.2165/11591560-000000000-00000
   PubMed Web of Science ®Google Scholar
• Armstrong EP. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 2010; 16(3):217-30; PMID: 20331326; https://doi.org/10.18553/jmcp.2010.16.3.217
   PubMed Web of Science ®Google Scholar
• Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS. A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer 2015; 121(11):1785-92; PMID: 25867018; https://doi.org/10.1002/cncr.29111
   PubMed Web of Science ®Google Scholar
• National Pharmacy Market Summary: Market Insights Report. SK&A: Irvine, CA (United States); 2016 [cited 2017 January 12]. Available from: http://www.skainfo.com/reports/most-powerful-pharmacies
   Google Scholar
• About NCPA. [cited 2017 January 12]; Available from: http://www.ncpanet.org/home/ncpa%27s-mission
   Google Scholar
• National Adult Immunization Plan (NAIP). United States Department of Health and Human Services, Washington, D.C. 2016 [cited 2017 January 11]. Available from: https://www.hhs.gov/sites/default/files/nvpo/national-adult-immunization-plan/naip.pdf
   Google Scholar
• Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med 2013; 11(5):429-36; PMID: 24019274; https://doi.org/10.1370/afm.1542
   PubMed Web of Science ®Google Scholar
• Sommers Hanson, J. Pharmacists engaging adults to be vaccinated. March 2017 Immunization Supplement: Pharmacy Times (R). Copyright © 2006–2017 Pharmacy & Healthcare Communications, LLC. 2017 [cited 2017 May 22]. Available from: http://www.pharmacytimes.com/publications/issue/2017/immunizationsupplementmarch2017/pharmacists-engaging-adults-to-be-vaccinated
   Google Scholar
• Kahan DM. A risky science communication environment for vaccines. Science 2013; 342(6154):53-4; PMID: 24092722; https://doi.org/10.1126/science.1245724
   PubMed Web of Science ®Google Scholar
• Koonin LM, Beauvais DR, Shimabukuro T, Wortley PM, Palmier JB, Stanley TR, Theofilos J, Merlin TL. CDC's 2009 H1N1 vaccine pharmacy initiative in the United States: implications for future public health and pharmacy collaborations for emergency response. Disaster Med Public Health Prep 2011; 5(4):253-5; PMID: 22146661; https://doi.org/10.1001/dmp.2011.83
   PubMed Web of Science ®Google Scholar
• Burson RC, Buttenheim AM, Armstrong A, Feemster KA. Community pharmacies as sites of adult vaccination: A systematic review. Hum Vaccin Immunother 2016; 12(12):3146-59; PMID: 27715409; https://doi.org/10.1080/21645515.2016.1215393
   PubMed Web of Science ®Google Scholar
• Bryan AR, Liu Y, Kuehl PG. Advocating zoster vaccination in a community pharmacy through use of personal selling. J Am Pharm Assoc (2003) 2013; 53(1):70-7; https://doi.org/10.1331/JAPhA.2013.11097
   Google Scholar
• Marotta R. Pharmacists remain among most trusted professions. Pharmacy Times (R). Copyright © 2006–2017 Pharmacy & Healthcare Communications, LLC. 2016 [cited 2017 January 20]. Available from: http://www.pharmacytimes.com/news/pharmacists-remain-among-most-trusted-professions
   Google Scholar
• Higginbotham S, Stewart A, Pfalzgraf A. Impact of a pharmacist immunizer on adult immunization rates. J Am Pharm Assoc (2003), 2012; 52(3):367-71; ; https://doi.org/10.1331/JAPhA.2012.10083
   Google Scholar
• Isenor JE, Edwards NT, Alia TA, Slayter KL, MacDougall DM, McNeil SA, Bowles SK. Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis. Vaccine 2016; 34(47):5708-23; PMID: 27765379; https://doi.org/10.1016/j.vaccine.2016.08.085
   PubMed Web of Science ®Google Scholar
• Calo WA, Gilkey MB, Shah P, Marciniak MW, Brewer NT. Parents' willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy. Prev Med 2017; 99:251-6; PMID: 28188796; https://doi.org/10.1016/j.ypmed.2017.02.003
   PubMed Web of Science ®Google Scholar
• Navarrete JP, Padilla ME, Castro LP, Rivera JO. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States/Mexico border. J Am Pharm Assoc (2003) 2014; 54(6):642-7; https://doi.org/10.1331/JAPhA.2014.13222
   Google Scholar
• The VFC Program: At a Glance. 2014 February 14, 2014 [cited 2017 January 10]; Available from: https://www.cdc.gov/vaccines/programs/vfc/about/index.html
   Google Scholar
• Lezin N, Baker S, Kingon R, McPhillips-Tangum C. Key considerations for pharmacies and the vaccines for children (vfc) program: Summary of interview and survey findings. 2015, Association of State and Territorial Health Officials by Cole Communications, Inc. p. 6.
   Google Scholar
• Tanzi MG. It takes a village: NVAC standards emphasize importance of immunization neighborhood. 2014.
   Google Scholar
• IIS State/Territory/City Registry Staff - Main & Technical Contacts. 2017 January 5, 2017 [cited 2017 January 14]; Available from: https://www.cdc.gov/vaccines/programs/iis/contacts-registry-staff.html#gu
   Google Scholar
• Bond KT, Jones K, Ompad DC, Vlahov D. Resources and interest among faith based organizations for influenza vaccination programs. J Immigr Minor Health 2013; 15(4):758-63; PMID: 22623183; https://doi.org/10.1007/s10903-012-9645-z
   PubMed Web of Science ®Google Scholar